Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immuron Limited (DE:ANW)
BERLIN:ANW
Immuron Limited (ANW) Stock Price & Analysis
0 Followers
ANW Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.03 - €0.11
Previous Close€0.05
Volume0.00
Average Volume (3M)78.70K
Market Cap
€14.61M
Enterprise Value-€1.42M
Total Cash (Recent Filing)AU$17.16M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)N/A
Beta0.51
Next Earnings
Aug 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding227,798,346
10 Day Avg. Volume0
30 Day Avg. Volume78,700
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)20.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immuron Limited News
PremiumCompany Announcements
Immuron CEO to Discuss Travelan® and Future Plans
PremiumPress Releases
Immuron to host Live Virtual EventPremiumCompany Announcements
Immuron Limited Previews Breakthrough Phase 3 TrialsPremiumPress Releases
Immuron Travelan® sales continued strong growth
PremiumCompany Announcements
Immuron’s Travelan® Sees Record Sales Growth
ANW FAQ
What was Immuron Limited’s price range in the past 12 months?
Immuron Limited lowest stock price was €0.03 and its highest was €0.11 in the past 12 months.
What is Immuron Limited’s market cap?
Currently, no data Available
When is Immuron Limited’s upcoming earnings report date?
Immuron Limited’s upcoming earnings report date is Aug 30, 2024 which is in 123 days.
How were Immuron Limited’s earnings last quarter?
Immuron Limited released its earnings results on Feb 28, 2024. The company reported -€0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.005.
Is Immuron Limited overvalued?
According to Wall Street analysts Immuron Limited’s price is currently Overvalued.
Does Immuron Limited pay dividends?
Immuron Limited does not currently pay dividends.
What is Immuron Limited’s EPS estimate?
Immuron Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immuron Limited have?
Currently, no data Available
What happened to Immuron Limited’s price movement after its last earnings report?
Immuron Limited reported an EPS of -€0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 33.333%.
Which hedge fund is a major shareholder of Immuron Limited?
Currently, no hedge funds are holding shares in DE:ANW
---
Immuron Limited Stock Smart Score
Company Description
Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
---
Technical Analysis
---